Tag: Cancer: Misc.
All-Cause, CVD, DM Mortality Down From 2000 to 2011
Decreases seen in type 1 and 2 diabetes; no change in age-standardized cancer-specific mortality
Adding Antiviral to Sorafenib Is Cost-Effective in HCC
More cost-effective than sorafenib monotherapy for HBV-related cancer
April 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2016. This roundup includes...
Costs for Orally Administered Cancer Drugs Up Since 2000
Gleevec shows one of the largest price increases
Ixazomib Ups Progression-Free Survival in Multiple Myeloma
Up in all prespecified patient groups, including those with high-risk cytogenetic abnormalities
American Association for Cancer Research, April 16-20
The American Association for Cancer Research Annual Meeting The annual meeting of the American Association for Cancer Research was held from April 16...
Metformin May Reduce Cancer Mortality Risk
Older women with diabetes and cancer taking metformin saw an increase in survival
Older Age May Boost Radiation Benefits in Soft-Tissue Sarcoma
Biggest benefit was seen post-surgery in people over 65, research suggests
Cancer Care and Fertility Program Improves Patient Satisfaction
Almost all males and females who received and read information materials found them helpful
March 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2016. This roundup includes...
